Bertrand C. Liang, M.D.
Vice President, Oncology / Hematology
Bertrand C. Liang, M.D. is IDEC’s Vice President, Oncology and Hematology. Dr. Liang leads all clinical product development in Oncology and Hematology.
Prior to joining IDEC, he was at Amgen Inc., responsible for directing novel compounds in development toward registration and providing medical marketing support of approved products. Previously, Dr. Liang held academic positions at the University of Vermont, the University of Colorado, and the National Institutes of Health.
Dr. Liang received a Doctor of Medicine from Northwestern University Medical School in Chicago, and has training in Neurology, Oncology, and Human Genetics.